Welcome to LookChem.com Sign In|Join Free

CAS

  • or

202120-10-3

Post Buying Request

202120-10-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

202120-10-3 Usage

General Description

Cyclohexanecarboxylic acid, 3-amino-, methyl ester, cis- (9CI) is a chemical compound that is a methyl ester derivative of 3-amino-cyclohexanecarboxylic acid. It exists in the cis conformation and is commonly used in organic synthesis and pharmaceutical research. Cyclohexanecarboxylic acid, 3-amino-, methyl ester, cis- (9CI) has potential applications in the development of pharmaceutical drugs and other bioactive molecules due to its unique structure and chemical properties. It is important to handle and use this compound with caution, as it may have specific health and safety risks associated with its handling and usage.

Check Digit Verification of cas no

The CAS Registry Mumber 202120-10-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,2,1,2 and 0 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 202120-10:
(8*2)+(7*0)+(6*2)+(5*1)+(4*2)+(3*0)+(2*1)+(1*0)=43
43 % 10 = 3
So 202120-10-3 is a valid CAS Registry Number.

202120-10-3Downstream Products

202120-10-3Relevant articles and documents

Asymmetric Synthesis of N-Substituted γ-Amino Esters and γ-Lactams Containing α,γ-Stereogenic Centers via a Stereoselective Enzymatic Cascade

Li, Ming,Cui, Yunfeng,Xu, Zefei,Chen, Xi,Feng, Jinhui,Wang, Min,Yao, Peiyuan,Wu, Qiaqing,Zhu, Dunming

supporting information, p. 372 - 379 (2021/10/25)

γ-Amino esters and γ-lactams containing α,γ-stereogenic centers are widely used as chiral intermediates in various bioactive compounds, while their efficient synthesis remains a challenge. Herein, an enzymatic cascade reaction involving an ene reductase (

Pyrimidopyrazole compound, preparation method and application thereof

-

Paragraph 0285; 0288; 0289, (2020/07/21)

The invention discloses a pyrimidopyrazole compound, a preparation method and application thereof. The invention provides a pyrimidopyrazole compound shown as formula I or pharmaceutically acceptablesalts thereof. The compound has a relatively good inhibition effect on CDK7.

INDAZOLE DERIVATIVES USEFUL AS ERK INHIBITORS

-

Page/Page column 101, (2012/07/13)

The present invention provides a compound of the Formula I, or a pharmaceutically acceptable salt, solvate or ester thereof, wherein R, R1, R2, R3, m and are as defined herein. The compounds are ERK inhibitors. Also disclosed are pharmaceutical compositions that comprise the above compounds, and methods of treating cancer using the same.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 202120-10-3